Gender and Age-Dependent Etiology of Community-Acquired Urinary Tract Infections

Table 4

Susceptibility rates to oral and parenteral antimicrobials of most common uropathogens isolated from urine samples.

Organism (n; %)	Antimicrobials
	CIP	LVX	NOR	NIT	SXT	AMP	AMC	FOS	PIP	TZP	CFZ	CRO	MRP	IMP	GEN	AMK
E. coli (9344;67.6%)	76.8	77.1	76.6	95.1	72.9	48.0	77.5	97.0	51.9	95.4	84.3	90.0	100	99.9	91.0	99.6
K. pneumonia (1204;8.7%)	93.6	93.0	95.3	35.1	89.8	0	81.4	81.0	61.8	92.3	78.3	87.9	99.7	99.9	92.9	97.1
E. faecalis (868;8.3%)	71.9	82.3	—	96.1	—	96.1	—	100.0	—	—	—	—	—	—	—	—
P. mirabilis (723;5.2%)	62.9	75.2	78.3	0	51.5	38.9	67.0	60.8	64.8	98.9	65.4	79.0	100	94.0	67.7	99.3
P. aeruginosa (345;2.3%)	57.7	58.7	60.6	0	0	0	0	0	88.4	95.9	0	0	94.7	93.3	68.0	83.7

—: not tested; CIP: ciprofloxacin; LVX: levofloxacin; NOR: norfloxacin; NIT: nitrofurantoin; SXT: trimethoprim-sulfamethoxazole; AMP: ampicillin; AMC: amoxicillin/clavulanic acid; FOS: fosfomycin; PIP: piperacillin; TZP: piperacillin/tazobactam; CFZ: cefazolin; CRO: ceftriaxone; MRP: meropenem; IMP: imipenem; GEN: gentamicin; AMK: amikacin.